PORTLAND, Ore. – Estudios recientes encontraron un aumento de las tasas de cáncer colorrectal en las generaciones de menos de 50 años. En Oregon la gente puede usar un proceso mejorado de detección que puede ser tomado en casa y enviado por correo. Comenta la doctora Tanya Kapka, directora médica de CareOregon.

Estudios recientes han detectado que la prevalencia de cáncer colorrectal está aumentando entre los "millennials" y la "Generación X". La detección puede ser una herramienta altamente efectiva para combatir el padecimiento. Durante marzo, Mes de la Conciencia del Cáncer Colorrectal, los profesionales de la medicina están informando cómo identificar y prevenir esta enfermedad tan altamente peligrosa. La colonoscopía constituye la herramienta de detección más efectiva y en Oregon existe también un examen, conocido como la prueba "FIT", que la gente puede usar en casa para la exploración del cáncer y luego enviarlo por correo. La doctora Tanya Kapka dice que nunca se insistirá demasiado en la importancia de examinarse.

"Sabemos que si hacemos el examen de cáncer colorrectal podemos incidir en los resultados. Es decir que los pacientes pueden detectarlo antes y tener más posibilidades de supervivencia, o incluso detectarlo antes de que se convierta en cáncer, como los pólipos precancerosos."

En los Estados Unidos, el cáncer colorrectal es la segunda causa de muertes vinculadas al cáncer en hombres, y la tercera en mujeres. Kapka dice que CareOregon trabaja en el estado en asociación con Organizaciones Coordinadas de Atención ("Coordinated Care Organizations") para surtir de pruebas de detección FIT a sus miembros. Agrega que durante el primer año en que repartieron las pruebas FIT, la detección de este cáncer aumentó casi un diez por ciento.

Kapka destaca que a pesar de los hallazgos recientes, la tasa de cáncer colorrectal ha bajado y más del 90 por ciento de los casos de cáncer colorrectal se presentan en gente de 50 años y más. Dice que los síntomas de cáncer en la gente joven incluyen sangrado rectal, nuevos dolores abdominales y cambios inexplicables del intestino. Debido al elevado riesgo para la gente de 50 años y más, Kapka dice que deben usar la prueba FIT cada año y además hacerse las colonoscopías normales.

"La razon por la que la colonoscopia es util es que no solo puede encontrar polipos pre-cancerosos y otras lesiones, sino que al mismo tiempo puede removerlos, y esos representarian canceres que estamos previniendo desde anos antes."

Kapka menciona que los africo-americanos tienen mayor riesgo de cáncer colorrectal y muchas sociedades médicas han sugerido que inicien los exámenes a una edad más temprana que el resto de la población. Agrega que el examen de cáncer colorrectal es uno de los 17 indicadores para mejorar los resultados de la salud de los pacientes.

Estudios recientes encontraron que la prevalencia de cancer colorrectal esta aumentando en los milenials y en la Generacion X. El examen de deteccion de cancer puede ser una herramienta altamente efectiva contra la enfermedad; un reporte de Eric Tegethoff (TEG-it-off).




get more stories like this via email

After more than 50 years of use, some Michigan lawmakers say naloxone may not be the best choice in an overdose situation.

Naloxone is sometimes called the "Lazarus drug" because of its powerful ability to seemingly resurrect people after a drug overdose.

Sen. Kevin Hertel, D-St. Clair Shores, and some of his colleagues have introduced a bill which would open the door for what they say are more costly, but more powerful, antidotes.

"Given the prevalence of fentanyl in our communities, and how much stronger some of these drugs that we're now seeing are, we believe -- and in talking with others -- that there should be other tools to respond to an overdose," Hertel explained. "To make sure we're doing everything we can to save somebody's life."

Not everyone is on board with the proposed legislation, Senate Bill 542. Opponents argued the more expensive naloxone alternatives are not necessary, and using them would only increase profits for the pharmaceutical industry.

Jonathan Stoltman, director of the Opioid Policy Institute in Grand Rapids, said while the naloxone alternatives do help in overdose situations, they can also cause nasty side effects.

"The newer approaches, they put people into more severe withdrawal," Stoltman pointed out. "That's a pretty profound negative side effect. The one approach is very inexpensive and works great; the other approach is far more expensive and has this strong negative side effect."

Sponsors of the bill say they're hoping to give Michigan residents a chance to chime in on the issue in a public hearing sometime in June. Michigan saw more than 3,000 opioid overdose deaths in 2021.


get more stories like this via email

New Mexico saw record enrollment numbers for the Affordable Care Act this year and is now setting its sights on lowering out-of-pocket costs - those not reimbursed by insurance. More than 56,000 New Mexicans are enrolled in a medical health insurance plan on the state exchange - an increase of 12,000 people overall.

Colin Baillio, deputy superintendent with the state's Office of Insurance, said the state has boosted its outreach and made efforts to improve the overall consumer experience.

"We saw a 40% year-over-year increase, and New Mexico saw the biggest percentage increase during the open-enrollment period among all of the state-based marketplaces," he explained

Part of the enrollment increase is due to what's called the "unwinding" - a federal directive that required all states to redetermine Medicaid eligibility following a three-year pause on checks during the COVID pandemic. He said by using expanded tools made available by the federal and state government, 8% of New Mexico's population is now uninsured - down from 23% in 2010.

Following approval by lawmakers in the 2024 legislative session, the New Mexico governor signed seven health care-related bills into law - one of which requires annual reporting of prescription drug pricing. Baililo said the Affordable Care Act built the foundation that has allowed the state to pursue additional affordability initiatives.

"I'm really glad to see that there's so much interest in the next step of health reform, really leaning into these out-of-pocket cost issues and making it easier for people to afford to stay covered and see their doctors," he continued.

Two years ago, the state also passed a one-of-a-kind law that did away with behavioral health co-pays for people in certain insurance plans.

New York's medical aid-in-dying bill is gaining further support. The Medical Society of the State of New York is supporting the bill. New York's bill allows terminally ill people with only six months to live to use this option, with safeguards requiring two physicians' approval.

The bill's Assembly sponsor Amy Paulin, D-Westchester, said despite the growing support, other hurdles lie ahead.

"Now we have what I believe, if it came to the floor, a majority. There's still a hesitation on the part of leadership. You know, we need members to assure leadership that they no longer have reservations," she said.

Other newly resolved concerns center on making sure insurance companies and doctors who don't support this aren't held liable. She's optimistic the bill will pass after nine years in the Legislature. New York would be the 11th state along with Washington, D.C. to have medical aid in dying legislation.

Corinne Carey, senior New York campaign director with Compassion and Choices finds the pandemic drew a vivid picture of a person's end-of-life experience. There were images of people dying on ventilators, apart from loved ones, and unable to communicate. She said people began thinking about a "good death."

"And, what is a good death is being surrounded by loved ones, having some measure of control, experiencing the touch of your loved ones, and being the one in the driver's seat," she explained.

Now people have different options for end-of-life care, each of which presents various challenges. Polls show medical aid in dying has garnered considerable support since being introduced in 2015. A 2022 Compassion and Choices poll finds 57% of nurses support medical aid in dying professionally, although fewer support it personally.